As of April 2024 Taro Pharmaceutical has a market cap of $1.59 Billion. This makes Taro Pharmaceutical the world's 4445th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.59 B | 1.68% |
2023 | $1.57 B | 43.87% |
2022 | $1.09 B | -42.05% |
2021 | $1.88 B | -32.95% |
2020 | $2.80 B | -17.11% |
2019 | $3.38 B | 2.61% |
2018 | $3.30 B | -21.35% |
2017 | $4.19 B | -2.79% |
2016 | $4.31 B | -34.75% |
2015 | $6.61 B | 4.29% |
2014 | $6.34 B | 43.36% |
2013 | $4.42 B | 105.34% |
2012 | $2.15 B | 64.12% |
2011 | $1.31 B | 110.47% |
2010 | $0.62 B | 79.1% |
2009 | $0.34 B | 15.47% |
2008 | $0.30 B | 0.01% |
2007 | $0.30 B | 2.8% |
2006 | $0.29 B | -28.28% |
2005 | $0.40 B | -58.76% |
2004 | $0.99 B | -46.87% |
2003 | $1.86 B | 72.88% |
2002 | $1.08 B | 2.86% |
2001 | $1.05 B |
On Apr 25th, 2024 the market cap of Taro Pharmaceutical was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $357.92 B | 22,318.05% | ๐บ๐ธ USA |
Novartis NVS | $202.12 B | 12,559.64% | ๐จ๐ญ Switzerland |
Pfizer PFE | $148.75 B | 9,217.01% | ๐บ๐ธ USA |
Merck MRK | $331.11 B | 20,639.00% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $83.58 B | 5,134.92% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.00 B | 839.97% | ๐ฎ๐ฑ Israel |